Biotech · Private company

Karius, Inc.

Track this companyFree. Adds Karius, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials82 recruiting or active

Pipeline programs3From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

Pipeline3

Microbial Cell-free Metagenomic Sequencing for Suspected Infections in Adult Immunocompromised OutpatientsNA · RECRUITING · started Oct 27, 2025ClinicalTrials.gov NCT07110636 · fetched Nov 12, 2026
Pneumonia in the ImmunoCompromised - Use of the Karius Test for the Detection of Undiagnosed PathogensCOMPLETED · started Nov 5, 2019ClinicalTrials.gov NCT04047719 · fetched Nov 12, 2026
Next-Generation Sequencing for Pathogen Detection and Quantification in Children With Musculoskeletal InfectionsNA · COMPLETED · started Sep 1, 2019ClinicalTrials.gov NCT03846804 · fetched Nov 12, 2026
Next Generation Sequencing Detection of Lyme DiseaseCOMPLETED · started Jul 24, 2018ClinicalTrials.gov NCT03505879 · fetched Nov 12, 2026
Use of NGS Cell-free Pathogen Test for Identification of Low Risk Fever & Neutropenia in Pediatric PatientsCOMPLETED · started May 7, 2018ClinicalTrials.gov NCT03530072 · fetched Nov 12, 2026
Next Generation Pathogen Sequencing for Prediction of Adverse EventsACTIVE_NOT_RECRUITING · started Aug 9, 2017ClinicalTrials.gov NCT03226158 · fetched Nov 12, 2026
Evaluation of NGS for Detection and Follow-up of Fungal Pathogens in Immunocompromised Pediatric PatientsCOMPLETED · started May 17, 2017ClinicalTrials.gov NCT03262584 · fetched Nov 12, 2026
The DISCOVER Trial (Diagnosis of Infection in Stem Cell Transplant Patients OVER Time)UNKNOWN · started Jul 1, 2016ClinicalTrials.gov NCT02804464 · fetched Nov 12, 2026